**Page:** 15

<!-- page break -->
A reconciliation of the Company's segment operating income to the Condensed Consolidated Statements of Operations for the three months ended December 30, 2023 and December 31, 2022 is as follows (in millions):

|                                  | Three Months Ended   | Three Months Ended   |
|----------------------------------|----------------------|----------------------|
|                                  | December 30, 2023    | December 31, 2022    |
| Segment operating income         | $ 50,088             | $ 45,405             |
| Research and development expense | (7,696)              | (7,709)              |
| Other corporate expenses, net    | (2,019)              | (1,680)              |
| Total operating income           | $ 40,373             | $ 36,016             |